Efficacy and Safety of Warfarin Experience in a Stroke Policlinic in Stroke Patients (original) (raw)
Efficacy and Safety of Warfarin Experience in a Stroke Polyclinic in Stroke Patients
Dursun Kırbaş
Nöropsikiyatri arşivi, 2017
View PDFchevron_right
Warfarin in patients with stroke and reasons for discontinuation
Cathy Helgason
Journal of Stroke and Cerebrovascular Diseases, 2004
View PDFchevron_right
A COMPARISON OF WARFARIN AND ASPIRIN FOR THE PREVENTION OF RECURRENT ISCHEMIC STROKE
Evin Chin
View PDFchevron_right
Prognosis in Patients Who were Diagnosed as Having Stroke, Using Warfarin, and Aged Over Eighty Years: A Clinical Observation
Eda Çoban
Turkish Journal Of Neurology, 2020
View PDFchevron_right
Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage: A Longitudinal Population-Based Study
Juha Huhtakangas
Stroke, 2011
View PDFchevron_right
Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Leanne Casaubon
Stroke, 2011
View PDFchevron_right
Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage
Pertti Saloheimo
Stroke, 2011
View PDFchevron_right
Intravenous thrombolysis in a patient taking warfarin with an international normalised ratio of 1.9
Naman Bhatt
2016
View PDFchevron_right
Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin
Nils Wahlgren
Annals of Neurology, 2013
View PDFchevron_right
Warfarin: An Inconvenient Truth
John Worthington
Stroke, 2009
View PDFchevron_right
FPIN's clinical inquiries. Warfarin for prevention of ischemic stroke recurrence?
John Noviasky
American family physician, 2006
View PDFchevron_right
Prehospital Reversal of Warfarin-Related Coagulopathy in Intracerebral Hemorrhage in a Mobile Stroke Treatment Unit
Peter Rasmussen
Stroke; a journal of cerebral circulation, 2015
View PDFchevron_right
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes
Elaine Hylek
Thrombosis research, 2013
View PDFchevron_right
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
Jonathan Rosand
Mayo Clinic Proceedings, 2007
View PDFchevron_right
Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention
Valeria Caso
Atherosclerosis, 2010
View PDFchevron_right
Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
Sam Schulman
Stroke, 2010
View PDFchevron_right
Re-initiation of oral-anticoagulants in survivors of hemorrhagic stroke
dinesh chaudhari
Apollo Medicine, 2017
View PDFchevron_right
Optimal Intensity of International Normalized Ratio in Warfarin Therapy for Secondary Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation
Takenori Yamaguchi
Internal Medicine, 2001
View PDFchevron_right
Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Noojan Kazemi
Archives of neurology, 2008
View PDFchevron_right
Intracranial Hemorrhages Related with Warfarin Use and Comparison of Warfarin and Acetylsalicylic Acid
Yeliz Çiftçi
Journal of Stroke and Cerebrovascular Diseases, 2014
View PDFchevron_right
Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC
Helmuth Steinmetz
PLoS ONE, 2011
View PDFchevron_right
Time trends in warfarin-associated hemorrhage
luis martin otagri castellanos
The American Journal of Cardiology, 2004
View PDFchevron_right
Improved survival of patients with warfarin-associated intracerebral haemorrhage: a retrospective longitudinal population-based study
Juha Huhtakangas
International Journal of Stroke, 2012
View PDFchevron_right
Increased Risk of Hemorrhagic Transformation in Ischemic Stroke Occurring During Warfarin Anticoagulation: An Experimental Study in Mice
Helmuth Steinmetz
Stroke, 2011
View PDFchevron_right
Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation
Nils Edvardsson
Journal of Internal Medicine, 2003
View PDFchevron_right
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation : A Multicenter, Prospective, Randomized Trial
Takenori Yamaguchi
Stroke, 2000
View PDFchevron_right